Erlotinib (Tarceva®):: Obtaining EU approval for treatment of metastasised pancreatic cancer

被引：0
|
作者：
不详
机构：
来源：
ONKOLOGIE | 2007年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [31] The effectiveness of erlotinib (Tarceva®) treatment in KRAS negative lung adenocarcinomas - preliminary results of an observational cohort study
    Ostoros, G.
    Sarosi, V.
    Losonczy, G.
    Tolnay, E.
    Moinar, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 559 - 559
  • [32] Treatment of metastasised breast cancer - Life extension or prolongation of life?
    Fabre, Pierre
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (06) : 36 - 37
  • [33] Cellular senescence predicts treatment outcome in metastasised colorectal cancer
    A M Haugstetter
    C Loddenkemper
    D Lenze
    J Gröne
    C Standfuß
    I Petersen
    B Dörken
    C A Schmitt
    British Journal of Cancer, 2010, 103 : 505 - 509
  • [34] Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer
    Boeck, Stefan
    Hausmann, Andreas
    Reibke, Roland
    Schulz, Christoph
    Heinemann, Volker
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1109 - 1111
  • [35] In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells
    Lupi, Monica
    Falcetta, Francesca
    D'Incalci, Maurizio
    Ubezio, Paolo
    CANCER RESEARCH, 2015, 75
  • [36] Integrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer
    Ubezio, Paolo
    Falcetta, Francesca
    Carrassa, Laura
    Lupi, Monica
    ONCOTARGET, 2016, 7 (13) : 15492 - 15506
  • [37] Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) - A Case Report
    Hass, H. G.
    Denzlinger, C.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (01): : 27 - 29
  • [38] GEMOX PLUS ERLOTINIB FOR THE TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA
    Fuereder, T.
    Kornek, G. V.
    Kuehrer, I.
    Zielinski, C.
    Klech, J.
    Scheithauer, W.
    ANNALS OF ONCOLOGY, 2012, 23 : 253 - 253
  • [39] Enzalutamide recommended for EU approval in advanced prostate cancer
    Lake, Francesca
    FUTURE ONCOLOGY, 2013, 9 (06) : 778 - 778
  • [40] Metastasised renal cell cancer - Study with Sunitinib in first line treatment
    不详
    UROLOGE, 2007, 46 (03): : 345 - 345
12345